Original Event Date: January 25-27, 2022
Time: 2:00 pm – 5:00 pm ET
The perseverance of women in science has been on full display this past year: they have made seminal scientific discoveries, taken up new leadership positions, started companies, and led the charge in the fight against COVID-19. The Rosalind Franklin Society celebrates these accomplishments, and many more, by recognizing, fostering, and advancing critical contributions from women in the life sciences and affiliated disciplines.
On January 25, 26, and 27 the Rosalind Franklin Society will host their annual end-of-year virtual conference co-sponsored by GEN. During this 3-day, complimentary event, we will hear insights from leaders in cutting-edge fields such as precision medicine and space exploration to large and small biotech industry leaders, as well as journalists, and new leadership in Washington. We know you will want to hear these presentations from prestigious scholars, authors, award winners, government leaders from NSF, OTPS, NASA, and the casting producer from Shark Tank!
To celebrate the life, work, and symbolic power of Dr. Franklin, the Society recognizes the work of outstanding women scientists, cultivates more significant opportunities for women in the sciences, and motivates and educates new generations of women who have this calling.
Guest Speakers
Brandon Andrews, Casting Director at Shark Tank
Baindu L. Bayon, PhD, Co-Host of “The STEM SiSTARS”, Co- Founder at Harpii LLC
Pamela Björkman, PhD, Professor of Biology and Bioengineering; Merkin Institute Professor; Executive Officer for Biology and Biological Engineering at California Institute of Technology
Laura Boykin Okalebo, PhD, Senior Scientific Consultant at BioTeam
Jennifer Buell, PhD, CEO at MiNK Therapeutics
Janice Chen, PhD, Co-founder and CTO at Mammoth Biosciences
Janine Austin Clayton, MD, FARVO, NIH Associate Director for Research on Women’s Health; Director, NIH Office of Research on Women’s Health
Rita Colwell, PhD, President at Rosalind Franklin Society
Ken Davidian, PhD, Director of Research, Federal Aviation Administration, Editor in Chief at New Space
Kevin Davies, PhD, Editor-at-Large at GEN
Hana El-Samad, PhD, Editor-in-Chief, GEN Biotechnology, Professor and Vice-Chair in the Department of Biochemistry and Biophysics at UCSF School of Medicine
Natalie Gomez-Ospina, MD, PhD, Assistant Professor of Pediatrics; Genetics and Stem Cell Transplantation, Medical Genetics at Stanford Bio-X
Jo Handelsman, PhD, Director of the Wisconsin Institute for Discovery, Vilas Research Professor, and Howard Hughes Medical Institute Professor at University of Wisconsin-Madison
Carolina Huaranca Mendoza, General Partner at First Close Partners
Dorothy Jones-Davis, PhD, Executive Director at Nation of Makers
Alicia J. Knoedler, PhD, Senior Designee for the White House Gender Policy Council; Head, Office of Integrative Activities, National Science Foundation
Julianna LeMieux, PhD, Senior Science Writer at GEN
Monica Lee Foley, Chief of Staff at NASA
Mary Ann Liebert, CEO at Mary Ann Liebert, Inc. publishers
Fay Lin, PhD, Senior Editor at GEN
Howard Markel, MD, PhD, Director, Center for the History of Medicine at University of Michigan
Kenna R Mills Shaw, PhD, Executive Director, Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy at MD Anderson
PK Morrow, MD, Vice President of Global Development & Therapeutic Area Head of Hematology at Amgen
Kavita Patel, MD, Columnist and Contributor at NBC News/MSNBC
Nabiha Saklayen, PhD, Co-founder and CEO at Cellino
Karla Shepard Rubinger, Executive Director at Rosalind Franklin Society
Lamont Terrell, PhD, Head of U.S, R&D, Early Talent Program at GSK
Meg Tirrell, Senior Health & Science Reporter at CNBC
Cassandra Wesselman, Head of Clinical Solutions and Patient Empowerment at Rosalind® Powered by OnRamp
Cynthia Wolberger, PhD, Director of the Department of Biophysics and Biophysical Chemistry, Professor of Biophysics and Biophysical Chemistry at Johns Hopkins School of Medicine
Betsy Zimmerman, Co-founder at First Close Partners
Ed Zimmerman, Partner at Lowenstein Sandler